Evidence map›Paper›PMID 40603827›Full record

ReviewPharmacological reports : PR2025

Behavioral tests to assess short- and long-lasting sensorimotor deficits following transient focal cerebral ischemia in rodents.

Enrique García-Alfonso, Jeney Ramírez-Sánchez, Maylin Wong-Guerra, Luis Arturo Fonseca-Fonseca, Yanay Montano-Peguero, Daniela Risco-Acevedo, Yanier Núñez-Figueredo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pharmacological reports : PR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Enrique García-Alfonso *Laboratory of Experimental Neuropharmacology, Center for Drug Research and Development (CIDEM), 26th Avenue 1605, Havana, 10600, Cuba.ORCID http://orcid.org/0000-0001-7789-6528
Jeney Ramírez-Sánchez *Neuroprotection Lab, Pharmaceutical Division, Center for Genetic Engineering and Biotechnology (CIGB), 31st Avenue 15802, Havana, 11600, Cuba. jeney.ramirez@cigb.edu.cu.ORCID http://orcid.org/0000-0003-2345-1923
Maylin Wong-GuerraDepartment of Biology, Faculty of Chemistry and Biology, Universidad de Santiago de Chile (USACH), Alameda, 3363, Santiago, Chile.ORCID http://orcid.org/0000-0002-8916-4620
Luis Arturo Fonseca-FonsecaLaboratory of Experimental Neuropharmacology, Center for Drug Research and Development (CIDEM), 26th Avenue 1605, Havana, 10600, Cuba.ORCID http://orcid.org/0000-0001-6904-5854
Yanay Montano-PegueroFaculty of Chemical and Pharmaceutical Sciences, Advanced Center for Chronic Diseases (ACCDiS), Universidad de Chile, Santos Dumont 964, Santiago, Chile.ORCID http://orcid.org/0000-0001-9436-235X
Daniela Risco-AcevedoNeuroprotection Lab, Pharmaceutical Division, Center for Genetic Engineering and Biotechnology (CIGB), 31st Avenue 15802, Havana, 11600, Cuba.ORCID http://orcid.org/0000-0001-6784-2446
Yanier Núñez-FigueredoLaboratory of Experimental Neuropharmacology, Center for Drug Research and Development (CIDEM), 26th Avenue 1605, Havana, 10600, Cuba.ORCID http://orcid.org/0000-0001-5633-4518

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebrovascular diseases are highly lethal and disabling events. Stroke is most commonly modeled using focal ischemia, of which middle cerebral artery occlusion (MCAO) is widely employed. Reproducible and reliable animal models are crucial for studying the pathophysiology of diseases and the evaluation of therapeutic candidates. However, despite showing efficacy in experimental studies, neuroprotective approaches have failed to translate into clinical benefit so far. A key measure to improve preclinical stroke research is the inclusion of functional endpoints intended to cover a wide range of parameters. The selection of appropriate tests is a critical issue and a challenging task, given the many variables to be considered. These variables include the experimental species, strain, sex, age, occlusion method and duration, infarct size and location, and degree of collateral irrigation, operational costs, among others. The focus of this review is on the behavioral tests most commonly used to identify neurological alterations associated with sensorimotor deficits following transient cerebral ischemia in rats and mice. Commonly used tests include the neurological score, the adhesive removal test, the hanging wire test, the corner test, the cylinder test, and the rotarod test. Functional endpoints must be included in preclinical testing, including sensorimotor and cognitive function, given the variable recovery rates of specific neurological functions. Importantly, screening for sensorimotor function prior to cognitive testing ensures accurate conclusions and helps identify the best specific conditions with minimal confounding by neurological abnormalities. Behavioral outcomes allow assessment of the severity, persistence, or recovery of post-ischemic injury over time.

Indexed as

Behavior, AnimalIschemic Attack, TransientAnimalsDisease Models, AnimalMiceRatsRodentiaBehavioral testsIschemic strokeMiddle cerebral artery occlusionPreclinical stroke modelsSensorimotor deficit

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.